Welcome to LookChem.com Sign In|Join Free

CAS

  • or

121470-24-4

Post Buying Request

121470-24-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-Oxa-6-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xy

    Cas No: 121470-24-4

  • No Data

  • 1 Kilogram

  • 1 Metric Ton/Day

  • Shandong Hanjiang Chemical Co., Ltd.
  • Contact Supplier
  • 1-Oxa-6-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xy

    Cas No: 121470-24-4

  • No Data

  • No Data

  • 10000 Metric Ton/Month

  • Henan Wentao Chemical Product Co., Ltd.
  • Contact Supplier
  • 1-Oxa-6-azacyclopentadecan-15-one,13-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xy

    Cas No: 121470-24-4

  • No Data

  • 10 Gram

  • 500 Kilogram/Month

  • Zibo Hangyu Biotechnology Development Co., Ltd
  • Contact Supplier

121470-24-4 Usage

General Description

Azithromycin Monohydrate is a semi-synthetic macrolide antibiotic used to treat a variety of bacterial infections. It works by inhibiting the growth of bacteria, thus helping to eliminate the infection. Azithromycin Monohydrate is commonly used to treat respiratory infections, skin infections, and sexually transmitted diseases. It is available in a variety of formulations, including oral tablets, capsules, and liquid suspension. The drug is generally well-tolerated and has a relatively low incidence of side effects. However, it is important to use Azithromycin Monohydrate only as prescribed by a healthcare professional, as misuse or overuse can lead to antibiotic resistance and decreased effectiveness over time.

Check Digit Verification of cas no

The CAS Registry Mumber 121470-24-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,4,7 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 121470-24:
(8*1)+(7*2)+(6*1)+(5*4)+(4*7)+(3*0)+(2*2)+(1*4)=84
84 % 10 = 4
So 121470-24-4 is a valid CAS Registry Number.
InChI:InChI=1S/C38H72N2O12.H2O/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28;/h20-33,35,41-43,45-46H,15-19H2,1-14H3;1H2/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-;/m1./s1

121470-24-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 11-((4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-2-ethyl-3,4,10-trihydroxy-13-((5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one hydrate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121470-24-4 SDS

121470-24-4Relevant articles and documents

Synthesis of 9-deoxo-9a-aza-9a-homoerythromycin A 11,12-hydrogen borate and azithromycin 11,12-hydrogen borate. A new procedure to obtain azithromycin dihydrate

Bayod-Jasanada,Carbajo,Lopez-Ortiz

, p. 7479 - 7481 (1997)

-

Process of preparing a crystalline azithromycin monohydrate

-

Page/Page column 5, (2008/06/13)

The present invention provides a process of preparing a crystalline azithromycin monohydrate. The process involves dissolving azithromycin in a solution containing ethanol, adding the dissolved azithromycin into water to precipitate the crystals, isolating and drying the precipitate to a water content of about 5% (w/w) to about 7% (w/w). The resulting azithromycin monohydrate is stable, exhibiting less than 2% degradation, and non-hydroscopic.

Stable non-dihydrate azithromycin oral suspensions

-

Page/Page column 16, (2008/06/13)

This invention relates to a powder for oral suspension, and an oral suspension made there from, which comprises non-dihydrate azithromycin and an azithromycin conversion stabilizing excipient, wherein said excipient reduces the conversion of the form of azithromycin, when placed in suspension, to another form of azithromycin. This invention further relates to a method for reducing the conversion of a form of non-dihydrate azithromycin, in an oral suspension, by adding a surface tension reducing excipient that reduces the surface tension of the aqueous vehicle. Furthermore, this invention relates to a method for reducing the conversion of a non-dihydrate azithromycin, in an unflavored oral suspension, by raising the viscosity of the oral suspension, and in a flavored oral suspension by lowering the viscosity of the oral suspension.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 121470-24-4